( MENAFN - GlobeNewsWire - Nasdaq) BROSSARD, Quebec, June 05, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the“Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces the closing of a second and final tranche of 3,502,931 units (each a“Unit”) issued at a price of $0.28 per Unit, for gross proceeds of $980,820.
68, of a non-brokered private placement initially announced on May 9, 2024 (“Private Placement”). Combined with the first closing announced on May 9, 2024, the aggregate number of Units is 4,627,931 and the aggregate gross proceeds amount to $1,295,820.68.
Each Unit consists of: As part of the closing of the second and final tranche of the Private Placement, 3,502,931 Warrants have been issued to the subscribers. Each Warrant can be exercised to purchase one Share at a price of $0.40 per Share for a period of 18 months ending December 5, 2025.
Combined with the first closing announced on May 9, 2024, the aggregate number of Warrants issued as part of the Private Placement is 4,627,931. The net proceeds from the Private Placement will be used to fund product development and commercialization of AI-based screening services as well as general and administrative operations. In connection with the closing of the second and final tranche of the Private Placement, the Corporation (i) paid cash commissions amounting to $27,804.
01 to three.
